Obstetrics/Gynecology General
RSSArticles
-
Washington Watch: Association issues call for annual conference
-
The Aspirin Story in Reducing the Incidence of Preeclampsia
-
Hormone Therapy and In-Hospital Survival after Myocardial Infarction in Postmenopausal Women
-
Estrogen Replacement and Improved Nonverbal Memory and Attentional Measures in Postmenopausal Women
-
HPV vaccine continues to be underutilized
According to new data from the Centers for Disease Control and Prevention's (CDC's) 2013 National Immunization Survey Teen, the number of girls and boys ages 13-17 years receiving human papillomavirus (HPV) vaccine remains unacceptably low, despite a slight increase in vaccination coverage since 2012. -
EC: Progress made, but challenges remain
Availability of emergency contraception (EC) has broadened since the FDA ruled that generic EC could be sold on store shelves and would no longer require proof of age. -
Biomedical prevention spotlighted at AIDS 2014
Data presented at the AIDS 2014 international conference indicates that oral HIV pre-exposure prophylaxis (PrEP) provides a high degree of protection against HIV infection, even for individuals who miss some daily doses. -
Future contraceptive? Microchip may be option
Science is looking at a wireless microchip implant, with remote drug delivery control, that is designed to last up to 16 years. -
Data mixed on increased risk of HIV in women using contraceptive shots
Presentations at the AIDS 2014 conference offer differing outlooks on increased risk of HIV in women using contraceptive injections. -
How to make LARC first at your clinic
Long-acting reversible contraception (LARC) — the copper T and levonorgestrel intrauterine devices (IUDs) and the birth control implant — are the most effective reversible methods available to prevent unintended pregnancy. They last for several years and are easy to use. Clinicians can draw lessons from the Contraceptive CHOICE project in St. Louis on how to make their clinics "LARC First.